Company: NKLR
Filing Date: 2025-09-03
Form Type: S-4/A
Source: 0001213900-25-084087
Chunk: 202

Company: Terra Innovatum Global N.V.
Filing Date: 2025-09-03
Form: S-4/A
Chunk 202
---
ergedas a suitable vehicle for advanced energy companies like Terra Innovatum seeking both capital and strategic visibility to scale and commercialize breakthrough technologies. 76

While Terra Innovatum did consider a public listing through a traditional IPO, it determined that the SPAC route offered a more compelling and strategic path forward. Most notably, the de -SPACprocess allows for an expedited timeline to public listing, increased transaction certainty amid evolving capital markets, and stronger market positioning — leveraging Terra Innovatum’s advanced nuclear technology and its potential to emerge as a leader in the next generation of clean energy solutions in respect to other peers. Importantly, this approach mirrors the successful public listings of other advanced nuclear companies such as NuScale, Oklo, and X -Energy, all of which have completed de -SPACtransactions resulting in multi -billion -dollarvaluations and heightened investor interest in the sector. The opportunity to partner with GSR III was another key driver. GSR III brings a highly experienced team with deep capital markets and SPAC expertise, having advised on 23 business combinations as advisors, and completed 2 business combinations as principals for GSR II Acquisition Corp. and Graf Acquisition Corp. IV, since 2020. This partnership offers Terra Innovatum not only capital access but also strategic advisory support as it transitions into its next phase of growth. The structure — anchored by a $475 million equity valuation and a shareholder -friendlyframework — was intentionally designed to promote long -terminvestor alignment and maximize value creation. Terra’s technology readiness was a key factor in the decision to pursue a SPAC transaction. Since its founding in 2018 and initial funding in 2021, Terra Innovatum has achieved meaningful progress toward commercialization, positioning itself ahead of many competitors still in early -stageR&D. Terra Innovatum’s reactor platform has been purposefully designed with specifications that materially de -riskboth its business model and regulatory pathway. These include the use of already licensed fuel (LEU), reliance on commercially available off -the -shelfcomponents, and a fully modular architecture with no requirement for an emergency planning zone. Together, these features significantly reduce technical and supply chain risks, while also enabling streamlined regulatory approvals and scalable, factory -basedproduction and deployment — propelled by the capital brought in part by the public listing. As a result, Terra Innovatum is uniquely positioned to accelerate its go -to -marketstrategy and manufacturing readiness in a sector where long development timelines are the norm. The timing of the transaction aligns with Terra Innovatum’s technology